Global Influenza Programme
We provide Member States with strategic guidance, technical support and coordination of activities essential to make their health systems better prepared against seasonal, zoonotic and pandemic influenza threats to populations and individuals.
WHO information for molecular diagnosis of influenza virus - update
This document provides information on molecular detection/diagnostic protocols updated as of the above date for surveillance of influenza viruses in humans.
List of revisions of this document:
- 7th revision: February 2021 (current version)
- 6th revision: January 2020 (current revision)
- 5th revision: November 2018
- 4th revision: July 2017
- 3rd revision: December 2016
- 2nd revision: May 2015
- 1st revision: March 2014
- Version 1: November 2012
The protocols are described in the annexes 1, 2, 3 and 4.
Annex 4 contains multiplex protocols for simultaneous detection of SARS-CoV-2 and influenza viruses in the same PCR reaction tube.
Revision February 2021:
- Annex 4. Protocol 1 added: Multiplex RT-PCR assay for the detection of Flu SARS-CoV-2 (page 61)
- Annex 4. Protocol 2 added: Real-time RT-PCR for the initial screening of SARS-CoV-2, Influenza A, B and C viruses (page 64)
- Annex 4. Protocol 3 added: One-step real-time RT-PCR 4-plex assay for the detection and subtyping of influenza A, B, H1pdm09 and H3 viruses(page 66)
For CDC RT-PCR protocols, please follow this link
Influenza A(H7N9)
- Real-time RT-PCR protocol for the detection of avian influenza A(H7N9) virus, provided by the WHO Collaborating Centre for Reference and Research in Beijing, China
pdf, 101kb
8 April 2013 (updated on 15 April)
View previous updates
- January 2020
pdf, 1.84Mb - November 2018
pdf, 1.73Mb - July 2017
pdf, 1.41Mb - May 2015
pdf, 1.20Mb - March 2014
pdf, 764kb - November 2012
pdf, 505kb - August 2011
pdf, 403kb - November 2009
pdf, 743kb